Lido Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Lido Advisors's EW Position: Q1 2026 in Review
Lido Advisors increased its Edwards Lifesciences (EW) stake by 1.3% in Q1 2026, buying an estimated $36.6K and bringing the position to 35,555 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #604.
Lido Advisors first reported a position in EW in Q1 2016 and has held it in 34 quarters since. The position peaked at $13.6M in Q3 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Lido Advisors held 35,555 shares of Edwards Lifesciences worth $2.85M as of Q1 2026.
- Lido Advisors bought 444 Edwards Lifesciences shares in Q1 2026, an estimated $36.6K.
- Edwards Lifesciences made up 0.01% of Lido Advisors's portfolio in Q1 2026, its #604 holding.
- Lido Advisors first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 34 quarters since.
- Lido Advisors's Edwards Lifesciences position peaked at $13.6M in Q3 2024.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.